rs201376373
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_005677.4(COLQ):c.106+6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00159 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005677.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.106+6T>C | splice_region_variant, intron_variant | ENST00000383788.10 | NP_005668.2 | |||
COLQ | NM_080539.4 | c.106+6T>C | splice_region_variant, intron_variant | NP_536800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.106+6T>C | splice_region_variant, intron_variant | 1 | NM_005677.4 | ENSP00000373298.3 | ||||
COLQ | ENST00000603808.5 | c.106+6T>C | splice_region_variant, intron_variant | 1 | ENSP00000474271.1 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 177AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00100 AC: 252AN: 251418Hom.: 0 AF XY: 0.00102 AC XY: 138AN XY: 135886
GnomAD4 exome AF: 0.00164 AC: 2395AN: 1461846Hom.: 1 Cov.: 32 AF XY: 0.00161 AC XY: 1173AN XY: 727224
GnomAD4 genome AF: 0.00116 AC: 177AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.00101 AC XY: 75AN XY: 74466
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 20, 2016 | - - |
COLQ-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at